Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Krystal Biotech (KRYS)
NASDAQ:KRYS
Krystal Biotech (KRYS) Ownership - Who Owns Krystal Biotech?
423 Followers
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| May 22, 2024 | Julian Gangolli Director | Sold | $3282597 |
| Jun 09, 2023 | Daniel Janney Director | Sold | $6417774 |
| Jun 02, 2023 | Suma Krishnan President, R&d,director, >10% Owner | Sold | $5809610 |
| Jun 02, 2023 | Krish Krishnan President & Ceo,director, >10% Owner | Sold | $5809610 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Mar 31, 2024 | Bought | $232020 | |
| Mar 31, 2024 | Sold | $16051954 | |
| Mar 31, 2024 | Sold | $19607708 | |
| Mar 31, 2024 | Sold | $49011708 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,318,952 | Institution | 8.12% | 371,148,268 | |
| 2,156,714 | Institution | 7.55% | 345,182,076 | |
| 2,070,322 | Institution | 7.25% | 331,355,036 | |
| 1,024,746 | Institution | 3.59% | 164,010,597 | |
| 943,614 | Institution | 3.30% | 151,025,421 | |
| 470,698 | Institution | 1.65% | 75,335,215 | |
| 401,877 | Institution | 1.41% | 64,320,414 | |
| 337,907 | Institution | 1.18% | 54,082,015 | |
| 275,455 | Institution | 0.96% | 44,086,573 | |
| 250,426 | Institution | 0.88% | 40,080,681 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,156,714 | Institution | 7.55% | 345,182,076 | |
| 2,070,322 | Institution | 7.25% | 331,355,036 | |
| 1,024,746 | Institution | 3.59% | 164,010,597 | |
| 401,877 | Institution | 1.41% | 64,320,414 | |
| 337,907 | Institution | 1.18% | 54,082,015 | |
| 250,426 | Institution | 0.88% | 40,080,681 | |
| 246,194 | Institution | 0.86% | 39,403,350 | |
| 243,421 | Institution | 0.85% | 38,959,531 | |
| 233,261 | Institution | 0.82% | 37,333,423 | |
| 171,917 | Institution | 0.60% | 27,515,316 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 760,231 | Institution | 2.66% | 116,406,571 | |
| 610,345 | Institution | 2.14% | 93,456,026 | |
| 495,426 | Institution | 1.73% | 79,292,931 | |
| 434,999 | Institution | 1.52% | 70,295,838 | |
| 409,251 | Institution | 1.43% | 62,664,513 | |
| 366,051 | Institution | 1.28% | 56,049,729 | |
| 182,194 | Institution | 0.64% | 29,160,150 | |
| 168,724 | Institution | 0.59% | 27,004,276 | |
| 116,944 | Institution | 0.41% | 18,898,150 | |
| 81,293 | Institution | 0.28% | 12,447,584 |
FAQ
Who Owns Krystal Biotech (KRYS)?
Currently, no data Available
What percentage of Krystal Biotech (KRYS) stock is held by institutional investors?
Currently, no data Available
What percentage of Krystal Biotech (KRYS) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Krystal Biotech (KRYS)?
Vanguard owns the most shares of Krystal Biotech (KRYS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.